Back to Trades
Congleton Jon
Chief Executive OfficerDirectorCIK 0001644975
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 13
- Buy transactions
- 0
- Sell transactions
- 18
- Companies
- 3
- Active
- 2025–2026
Congleton Jon, Chief Executive Officer, Director, accounts for 13 disclosed filings worth $16.6M, spread across 3 companies, active 2025–2026. The record is heavily weighted toward selling, with $0 in purchases against $15.1M in sales. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
13 loaded
| Jul 15 | MLYS Mineralys Therapeutics, Inc. | Congleton Jon | Chief Executive Officer, Director | Sell | $291.4K |
| Jul 7 | IMUX IMMUNIC, INC. | Congleton Jon | Director | Award | $375.5K |
| Jun 30 | MLYS Mineralys Therapeutics, Inc. | Congleton Jon | Chief Executive Officer, Director | Sell | $2.0M |
| Jun 29 | IMUX IMMUNIC, INC. | Congleton Jon | Director | Award | $553.1K |
| May 1 | AVLN Avalyn Pharma Inc. | Congleton Jon | Insider | Award | $485.6K |
| Apr 29 | AVLN Avalyn Pharma Inc. | Congleton Jon | Insider | Other | $0 |
| Apr 15 | MLYS Mineralys Therapeutics, Inc. | Congleton Jon | Chief Executive Officer, Director | Sell | $422.0K |
| Apr 2 | MLYS Mineralys Therapeutics, Inc. | Congleton Jon | Chief Executive Officer, Director | Sell | $2.0M |
| Jan 13 | MLYS Mineralys Therapeutics, Inc. | Congleton Jon | Chief Executive Officer, Director | Sell | $529.6K |
| Nov 24 | MLYS Mineralys Therapeutics, Inc. | Congleton Jon | Chief Executive Officer, Director | Exercise | $13.0K |
| Nov 13 | MLYS Mineralys Therapeutics, Inc. | Congleton Jon | Chief Executive Officer, Director | Sell | $9.1M |
| Oct 15 | MLYS Mineralys Therapeutics, Inc. | Congleton Jon | Chief Executive Officer, Director | Sell | $644.3K |
| Jul 15 | MLYS Mineralys Therapeutics, Inc. | Congleton Jon | Chief Executive Officer, Director | Sell | $230.4K |
13 filings